We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
226
KLA
KLAC
$222B
$11.5M 0.1%
461,690
AMP icon
227
Ameriprise Financial
AMP
$47.8B
$11.5M 0.1%
61,477
CNST
228
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$11.4M 0.09%
411,515
+3
+0% +$91
CHRS icon
229
Coherus Oncology
CHRS
$217M
$11.4M 0.09%
680,812
-45
-0% -$764
RF icon
230
Regions Financial
RF
$26.4B
$11.4M 0.09%
733,357
CCI icon
231
Crown Castle
CCI
$34.6B
$11.3M 0.09%
73,976
MCHP icon
232
Microchip Technology
MCHP
$38.8B
$11.2M 0.09%
168,716
SLB icon
233
SLB Ltd
SLB
$72.7B
$11.2M 0.09%
532,942
ARGX icon
234
argenx
ARGX
$55.2B
$11M 0.09%
38,773
-4
-0% -$1.26K
GH icon
235
Guardant Health
GH
$19.1B
$10.9M 0.09%
88,352
CL icon
236
Colgate-Palmolive
CL
$74.8B
$10.9M 0.09%
132,817
+20
+0% +$1.57K
URI icon
237
United Rentals
URI
$65.7B
$10.7M 0.09%
48,052
TWTR
238
DELISTED
Twitter, Inc.
TWTR
$10.6M 0.09%
204,005
AXP icon
239
American Express
AXP
$224B
$10.5M 0.09%
90,162
+2
+0% +$264
SLF icon
240
Sun Life Financial
SLF
$45.6B
$10.4M 0.09%
244,201
CAT icon
241
Caterpillar
CAT
$361B
$10.4M 0.09%
59,469
MCD icon
242
McDonald's
MCD
$193B
$10.4M 0.09%
50,440
-2
-0% -$428
BDX icon
243
Becton Dickinson
BDX
$46.4B
$10.3M 0.09%
44,121
HCA icon
244
HCA Healthcare
HCA
$90.6B
$10.2M 0.09%
64,755
RCUS icon
245
Arcus Biosciences
RCUS
$3.33B
$10.2M 0.08%
408,991
-15
-0% -$522
TROW icon
246
T. Rowe Price
TROW
$25.5B
$10.1M 0.08%
69,553
AGIO icon
247
Agios Pharmaceuticals
AGIO
$2.08B
$10.1M 0.08%
241,987
IPHI
248
DELISTED
INPHI CORPORATION
IPHI
$9.75M 0.08%
63,252
DCPH
249
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$9.68M 0.08%
176,655
+19
+0% +$885
A icon
250
Agilent Technologies
A
$39.6B
$9.64M 0.08%
84,736
+17
+0% +$2.1K

Similar funds

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.